3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Renal Cell
4
Neoplasms
3
Multiple Myeloma
3
Gastrointestinal Stromal Tumors
3
Thyroid Neoplasms
2
Pancreatic Neoplasms
2
Neoplasm Metastasis
2
Lymphoma
2
Gastrointestinal Neoplasms
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Stomach Neoplasms
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Ovarian Neoplasms
1
Metastatic Digestive System Neuroendocrine Tumor G1
1
Meningioma
1
Melanoma
1
Lymphoma, Non-Hodgkin
1
Lung Neoplasms
1
Hematologic Neoplasms
1
Glioma
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Hepatocellular
1
Carcinoma
1
Interventions
Cyclophosphamide
6
fludarabine phosphate
5
fludarabine
5
Whole-Body Irradiation
4
Busulfan
4
Biopsy
4
Specimen Handling
3
Injections
3
Cytarabine
3
venetoclax
2
decitabine and cedazuridine drug combination
2
Tacrolimus
2
Stem Cell Transplantation
2
Peripheral Blood Stem Cell Transplantation
2
Mycophenolic Acid
2
Melphalan
2
Lenalidomide
2
Granulocyte Colony-Stimulating Factor
2
Filgrastim
2
Cyclosporine
2
CPX-351
2
Azacitidine
2
treosulfan
1
peginterferon alfa-2b
1
olutasidenib
1
itacitinib
1
canakinumab
1
aldesleukin
1
X-Rays
1
Vorinostat
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Myelomonocytic, Chronic
×
Sunitinib
×
30 days
×
Clear all
No trials found.